Article Information
History
- November 27, 2020.
Article Versions
- Version 1 (November 24, 2020 - 10:36).
- Version 2 (November 25, 2020 - 15:38).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Aidan M. Nikiforuk, MSc.1,4,*,
- Kevin S. Kuchinski, BSc.1,2,*,
- David D.W. Twa, PhD2,3,*,
- Christine D. Lukac, MPH1,
- Hind Sbihi, PhD1,4,
- C. Andrew Basham, MSc.1,4,
- Christian Steidl, MD3,
- Natalie A. Prystajecky, PhD1,2,
- Agatha N. Jassem, PhD1,2,
- Mel Krajden, MD1,2,
- David M Patrick, MD1,4 and
- Inna Sekirov, PhD1,2,#
- 1British Columbia Centre for Disease Control, Vancouver, V5Z 4R4, British Columbia, Canada
- 2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, V6T 1Z4, British Columbia, Canada
- 3British Columbia Cancer Research Centre, Vancouver, V5Z 1L3, British Columbia, Canada
- 4School of Population and Public Health, University of British Columbia, Vancouver, V6T 1Z4, British Columbia, Canada
- ↵#Corresponding Author:
Dr. Inna Sekirov MD/ PhD, British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada, V5Z 4R4 and Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, V6T 1Z4. email: inna.sekirov{at}bccdc.ca
↵* these authors contributed equally to the work.
Posted November 27, 2020.
The Contrasting Role of Nasopharyngeal Angiotensin Converting Enzyme 2 (ACE2) Expression in SARS-CoV-2 Infection: A Cross-Sectional Study of People Tested for COVID-19 in British Columbia
